Literature DB >> 18424135

Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.

Artem Melman1, Zhan-Guo Gao, Deepmala Kumar, Tina C Wan, Elizabeth Gizewski, John A Auchampach, Kenneth A Jacobson.   

Abstract

2-Chloro-5'-N-methylcarboxamidoadenosine analogues containing the (N)-methanocarba (bicyclo[3.1.0]hexane) ring system as a ribose substitute display increased selectivity as agonists of the human A(3) adenosine receptor (AR). However, the selectivity in mouse was greatly reduced due to an increased tolerance of this ring system at the mouse A(1)AR. Therefore, we varied substituents at the N(6) and C2 positions in search of compounds that have improved A(3)AR selectivity and are species independent. An N(6)-methyl analogue was balanced in affinity at mouse A(1)/A(3)ARs, with high selectivity in comparison to the A(2A)AR. Substitution of the 2-chloro atom with larger and more hydrophobic substituents, such as iodo and alkynyl groups, tended to increase the A(3)AR selectivity (up to 430-fold) in mouse and preserve it in human. Extended and chemically functionalized alkynyl chains attached at the C2 position of the purine moiety preserved A(3)AR selectivity more effectively than similar chains attached at the 3-position of the N(6)-benzyl group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424135      PMCID: PMC2430186          DOI: 10.1016/j.bmcl.2008.04.001

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  33 in total

1.  2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists.

Authors:  Elfatih Elzein; Venkata Palle; Yuzhi Wu; Tenning Maa; Dewan Zeng; Jeff Zablocki
Journal:  J Med Chem       Date:  2004-09-09       Impact factor: 7.446

2.  Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor.

Authors:  Lak Shin Jeong; Hyuk Woo Lee; Kenneth A Jacobson; Hea Ok Kim; Dae Hong Shin; Jeong A Lee; Zhan-Guo Gao; Changrui Lu; Heng T Duong; Prashantha Gunaga; Sang Kook Lee; Dong Zhe Jin; Moon Woo Chun; Hyung Ryong Moon
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

3.  2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.

Authors:  Liesbet Cosyn; Krishnan K Palaniappan; Soo-Kyung Kim; Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson; Serge Van Calenbergh
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

4.  A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.

Authors:  K A Jacobson; R Xie; L Young; L Chang; B T Liang
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

5.  Activation of various subtypes of G-protein alpha subunits by partial agonists of the adenosine A1 receptor.

Authors:  A Lorenzen; H Lang; U Schwabe
Journal:  Biochem Pharmacol       Date:  1998-11-15       Impact factor: 5.858

6.  The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition.

Authors:  Lea Madi; Avivit Ochaion; Lea Rath-Wolfson; Sara Bar-Yehuda; Abigail Erlanger; Gil Ohana; Arie Harish; Ofer Merimski; Faina Barer; Pnina Fishman
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

7.  N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.

Authors:  Lak Shin Jeong; Dong Zhe Jin; Hea Ok Kim; Dae Hong Shin; Hyung Ryong Moon; Prashantha Gunaga; Moon Woo Chun; Yong-Chul Kim; Neli Melman; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2003-08-28       Impact factor: 7.446

8.  Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position.

Authors:  Michihiro Ohno; Zhan-Guo Gao; Philippe Van Rompaey; Susanna Tchilibon; Soo-Kyung Kim; Brian A Harris; Ariel S Gross; Heng T Duong; Serge Van Calenbergh; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2004-06-01       Impact factor: 3.641

9.  Adenosine A3 receptor activation modulates the capillary endothelial glycocalyx.

Authors:  Steven H Platts; Brian R Duling
Journal:  Circ Res       Date:  2003-11-20       Impact factor: 17.367

10.  3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor.

Authors:  Michael P DeNinno; Hiroko Masamune; Lois K Chenard; Kenneth J DiRico; Cynthia Eller; John B Etienne; Jeanene E Tickner; Scott P Kennedy; Delvin R Knight; Jimmy Kong; Joseph J Oleynek; W Ross Tracey; Roger J Hill
Journal:  J Med Chem       Date:  2003-01-30       Impact factor: 7.446

View more
  24 in total

Review 1.  Recent developments in adenosine receptor ligands and their potential as novel drugs.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.

Authors:  Dilip K Tosh; Moshe Chinn; Andrei A Ivanov; Athena M Klutz; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

Review 3.  Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

Authors:  Kenneth A Jacobson; Athena M Klutz; Dilip K Tosh; Andrei A Ivanov; Delia Preti; Pier Giovanni Baraldi
Journal:  Handb Exp Pharmacol       Date:  2009

Review 4.  Introduction to adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2009

5.  Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.

Authors:  Won Jun Choi; Hyuk Woo Lee; Hea Ok Kim; Moshe Chinn; Zhan-Guo Gao; Amit Patel; Kenneth A Jacobson; Hyung Ryong Moon; Young Hoon Jung; Lak Shin Jeong
Journal:  Bioorg Med Chem       Date:  2009-10-12       Impact factor: 3.641

Review 6.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

7.  Species differences and mechanism of action of A3 adenosine receptor allosteric modulators.

Authors:  Lili Du; Zhan-Guo Gao; Silvia Paoletta; Tina C Wan; Elizabeth T Gizewski; Samantha Barbour; Jacobus P D van Veldhoven; Adriaan P IJzerman; Kenneth A Jacobson; John A Auchampach
Journal:  Purinergic Signal       Date:  2017-11-23       Impact factor: 3.765

8.  Characterization of the A2B adenosine receptor from mouse, rabbit, and dog.

Authors:  John A Auchampach; Laura M Kreckler; Tina C Wan; Jason E Maas; Dharini van der Hoeven; Elizabeth Gizewski; Jayashree Narayanan; Garren E Maas
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

9.  Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.

Authors:  Lak Shin Jeong; Shantanu Pal; Seung Ah Choe; Won Jun Choi; Kenneth A Jacobson; Zhan-Guo Gao; Athena M Klutz; Xiyan Hou; Hea Ok Kim; Hyuk Woo Lee; Sang Kook Lee; Dilip K Tosh; Hyung Ryong Moon
Journal:  J Med Chem       Date:  2008-09-24       Impact factor: 7.446

Review 10.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.